Peng, N.-X., Liu, C.-X., Wang, X.-S., Zhang, Z.-J., & Liao, S.-C. (2015). Combination of axitinib and dasatinib for anti-cancer activities in two prostate cancer cell lines. Bangladesh Journal of Pharmacology, 11(1), 130–137. https://doi.org/10.3329/bjp.v11i1.24149